The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) offers this intensive practicum to provide fundamental knowledge of dietary supplements geared toward faculty, Ph.D. students, and postdocs at academic institutions; health care practitioners; and other professionals with advanced biomedical degrees. Since the practicum will be held this year virtually, we have decided to open it up to a broader audience. Its three main goals are to::
Day 1 - Tuesday, May 25 |
| |
SESSION 1: SETTING THE STAGE
|
11:00 a.m. |
Welcome and Introductions: What ODS Does
Jaime Gahche, Ph.D., Practicum Director, ODS, NIH
|
11:30 a.m. |
Overview of Dietary Supplement Use
Regan Bailey, Ph.D., M.P.H., R.D., Purdue University
|
12:15 p.m. |
Motivations for Dietary Supplement Use
Johanna Dwyer, D.Sc., R.D., ODS, NIH
Objectives: (1) Provide follow-up to a previous presentation with a focus on why people report they take supplements; (2) discuss the strengths and weaknesses of methodologies to collect this information; (3) explore whether reasons for use differ depending on number and types of supplements taken; and (4) describe results from the National Health Interview Survey on motivations for supplement use.
|
1:00 p.m. |
Break |
| |
SESSION 2: RESEARCH AND REGULATION
|
| |
Moderator: Paul Thomas, Ed.D., R.D.N., ODS, NIH
|
1:10 p.m. |
What the U.S. Food and Drug Administration (FDA) Does
Anthony Lee, J.D., M.P.A., Center for Food Safety and Applied Nutrition, Office of Dietary Supplement Programs, Division of Policy and Regulations Implementation, U.S. Food and Drug Administration (FDA)
Objectives: (1) Describe FDA’s supplement-related responsibilities and how its regulation of these products differs from those covering conventional foods and medicines; (2) explain FDA’s role in regulating supplements versus the manufacturer’s responsibility for marketing them; (3) discuss FDA’s post-marketing responsibilities for supplements, including safety monitoring and the provision of product information; and (4) provide information about when supplements require an Investigational New Drug (IND) application.
|
1:55 p.m. |
Food vs. Drugs vs. Dietary Supplements
Joseph Betz, Ph.D., Acting Director of ODS, NIH
Objectives: (1) Provide information on the principles on how food, drugs, and dietary supplements are regulated; (2) explain the differences in labeling requirements for foods and dietary supplements; and (3) provide real-life examples encountered by companies that inadvertently crossed the lines between conventional foods, dietary supplements, and drugs when they introduced new products to the market.
|
2:40 p.m. |
What the Federal Trade Commission (FTC) Does
Tawana Davis, J.D., Division of Advertising Practices in the Bureau of Consumer Protection at the U.S. Federal Trade Commission (FTC)
Objectives: (1) Explain FTC’s supplement-related responsibilities and how its regulation of these products differs from conventional foods; and (2) describe several FTC activities related to ensuring that supplement advertising is truthful and not misleading, and regulatory actions it has taken against offenders.
|
3:25 p.m. |
Panel Discussion |
3:45 p.m. |
Break |
| |
SESSION 3: NIH FUNDING OPPORTUNITIES
|
| |
Moderator: Nancy Potischman, Ph.D., ODS, NIH
|
3:55 p.m. |
NIH Support for Research and Training on Nutrition and Dietary Supplements
Abby Ershow, Sc.D., R.D., ODS, NIH
Objectives: (1) Describe the NIH extramural funding system; (2) Describe different types of funding mechanisms and funding opportunities; and (3) Describe which federal agencies provide funding for nutrition research and training.
|
4:40 p.m. |
Adjourn |
Day 2 - Wednesday, May 26 |
| |
SESSION 4: EFFICACY AND SAFETY
|
| |
Moderator: Rebecca Costello, Ph.D., ODS, NIH
|
11:00 a.m. |
Efficacy and Effectiveness: Lines of Evidence in Supplement Research
Howard Sesso, Sc.D., M.P.H., Harvard Medical School
Objectives: (1) Explain the concepts of efficacy and effectiveness, and how they are defined, measured, studied, and reported in regard to dietary supplements; (2) provide examples of research with dietary supplements to try to evaluate these concepts; and (3) describe the different types of research studies used to determine efficacy and effectiveness.
|
11:45 a.m. |
Safety: The Concept of Safety, Its Measurement, and Reporting
Mary Hardy, M.D., George Washington University Medical School
Objectives: (1) Explain the concept of safety and how it is defined, measured, studied, and reported in regard to dietary supplements; (2) provide examples to illustrate the ways in which the safety of various supplement ingredients have been evaluated; and (3) discuss the patchwork of systems in place to monitor for adverse effects of supplements and how safety concerns vary by population subgroups.
|
12:30 p.m. |
Interactions between Supplements and Drugs
Bill Gurley, Ph.D., University of Arkansas
for Medical Sciences College of Pharmacy
Objectives: (1) Describe some major means and mechanisms by which ingredients in supplements and medicines may interact and the potential clinical implications of these interactions; (2) illustrate these concepts with examples; and (3) discuss the extent to which interactions between supplements and drugs are studied, reported by health professionals, pose clinically relevant risks to consumers, and are catalogued in places accessible to health professionals and consumers.
|
1:25 p.m. |
Break |
| |
SESSION 5: RIGOR AND REPRODUCIBILITY IN DIETARY SUPPLEMENTS RESEARCH
|
| |
Moderator: Sanem Hosbas Coskun, Ph.D. and Stephen Wise, Ph.D., ODS, NIH
|
1:30 p.m. |
Analytical Characterization of Dietary Supplements: Methods, Standards, and Quality Assurance
Adam Kuszak, Ph.D., ODS, NIH
Objectives: (1) Introduce the principles of dietary supplement characterization by introducing the concepts of identity, purity, quality, and composition; (2) provide an overview of the analytical challenges and needs in dietary supplement research, and the importance of standards and reference materials; (3) describe the work of federal agencies and nongovernment organizations to develop analytical methods and reference materials to enhance dietary supplement research and assess product quality.
|
2:15 p.m. |
Challenges in Research on Botanical Dietary Supplements
Barbara Sorkin, Ph.D., ODS, NIH
Objectives: (1) Illustrate how concepts of efficacy, safety, and identity/quality are addressed in studying botanicals and plant-derived ingredients; and (2) provide an overview of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (CARBON) Program, research emphases, and examples of research activity.
|
3:00 p.m. |
Break |
| |
SESSION 6: SPECIAL TOPICS
|
| |
Moderator: Laverne Brown, Ph.D., ODS, NIH
|
3:15 p.m. |
Dietary Supplements in the Time of COVID-19
Carol Haggans, M.S., R.D., ODS, NIH
Objectives: (1) Provide an overview of the types of dietary supplements that might affect immune function and inflammation; and (2) summarize the scientific evidence with respect to COVID-19 for selected ingredients in these products and the quality of that evidence.
|
4:00 p.m. |
Dietary Supplement Databases
Joyce Merkel, M.S., R.D., ODS, NIH
Objectives: (1) Describe the purpose and value of several databases that provide information on dietary supplement ingredients; (2) illustrate the content and navigation of these databases; and (3) comment on the value and limitations of these resources.
|
4:45 p.m. |
Adjourn |
Day 3 - Thursday, May 27 |
| |
SESSION 6: SPECIAL TOPICS CONTINUED
|
11:00 a.m. |
Emerging Science: The Microbiome and Nutrition
Cindy D. Davis, Ph.D., ODS, NIH
Objectives: (1) Define the human microbiome; (2) describe the evidence that diet and dietary supplements con modulate the gastrointestinal microbial community structure; (3) describe the evidence that the gastrointestinal microbiome can influence the response to dietary components; (4) describe the relationship between dietary components and the microbiome and chronic diseases such as obesity, cardiovascular disease, and cancer.
|
11:45 a.m. |
Dietary Supplements and the U.S. Department of Defense
Jonathan Scott, Ph.D. and Andrea Lindsey, M.S., Uniformed Services University of the Health Sciences
Objectives: (1) Describe dietary supplement use in the Department of Defense (DoD); (2) Identify issues associated with dietary supplement use within the DoD; (3) Introduce ongoing DoD dietary supplement research initiatives; and (4) Introduce Operation Supplement Safety.
|
12:30 p.m. |
Break |
| |
SESSION 7: MEETING THE STAKEHOLDERS
Moderator: Leila Saldanha, Ph.D., R.D., ODS, NIH
Attendees will hear from those who study, advocate, regulate, or educate on dietary supplements. Topics for speakers to address include: (1) Describe the purposes of your organization in relation to dietary supplements and what its perspectives and views are regarding these products; and (2) describe your activities in matters related to supplements (including manufacture, marketing, and regulation) and in providing information/education about these products.
|
|
Panel 1: A Conversation With the Industry
|
12:45 p.m. |
Jay Sirois, Ph.D., Consumer Healthcare Products Association
|
1:00 p.m. |
Merle Zimmermann, Ph.D., American Herbal Products Association
|
1:15 p.m. |
Brian Wommack, J.D., Council for Responsible Nutrition
|
1:30 p.m. |
Panel Discussion |
|
Panel 2: Meet the Watchdogs
|
1:45 p.m. |
Tod Cooperman, M.D., ConsumerLab.com
|
2:00 p.m. |
Laura MacCleery, Center for Science in the Public Interest
|
2:15 p.m. |
Media person, TBD
|
2:30 p.m. |
Panel Discussion |
2:45 p.m. |
Break |
3:00 p.m. |
Panel Discussion: Panel 1 and Panel 2 |
3:30 p.m. |
Final Wrap-up to Practicum
|
3:45 p.m. |
Adjourn |
